Metraipolis › archive › dc_eaef3f55051d

CYP4X1/sEH-Dependent Endocannabinoid Metabolism Drives Fibroblast-Mediated Immunosuppression to Limit Immunotherapy in Colon Cancer — Europe PMC PMID:41276938

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41276938
DOI: 10.1002/advs.202507695
License (as archived): solo-consultazione
Archived: 2026-11-08T08:00:20.075Z
SHA-256 of the archived text: 8ea80f8cd8986dcacc3c6015b28c5f862a26e596ed1f4a86637d23e85fc62987
Stable URL of this page: https://metraipolis.com/documento/dc_eaef3f55051d

How to cite

CYP4X1/sEH-Dependent Endocannabinoid Metabolism Drives Fibroblast-Mediated Immunosuppression to Limit Immunotherapy in Colon Cancer — Europe PMC PMID:41276938 — Europe PMC (en), https://europepmc.org/article/MED/41276938 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaef3f55051d (Metraipolis archive dc_eaef3f55051d, sha256 8ea80f8cd8986dcacc3c6015b28c5f862a26e596ed1f4a86637d23e85fc62987)

BibTeX

@misc{dceaef3f55051d,
  title = {CYP4X1/sEH-Dependent Endocannabinoid Metabolism Drives Fibroblast-Mediated Immunosuppression to Limit Immunotherapy in Colon Cancer — Europe PMC PMID:41276938},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41276938},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaef3f55051d; sha256 8ea80f8cd8986dcacc3c6015b28c5f862a26e596ed1f4a86637d23e85fc62987},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41276938. Agents can read the archived copy with the MCP tool read_document.